Short-Term (6 Weeks) Experience of a Modular Workcell for Hemostasis Testing Including an Intelligent Data Manager at a Tertiary Care Hospital.

Hwan Tae Lee, So Young Lee, Ja Young Seo, Jeong-Yeal Ahn
{"title":"Short-Term (6 Weeks) Experience of a Modular Workcell for Hemostasis Testing Including an Intelligent Data Manager at a Tertiary Care Hospital.","authors":"Hwan Tae Lee,&nbsp;So Young Lee,&nbsp;Ja Young Seo,&nbsp;Jeong-Yeal Ahn","doi":"10.1093/labmed/lmac156","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Modular workcells could be a better solution than total laboratory automation (TLA) in hemostasis laboratories. Here, we evaluated the impact of implementing a modular workcell (HemoCell) with an intelligent data management facility (HemoHub).</p><p><strong>Methods: </strong>We compared the turnaround times (TATs), numbers of rerun samples, and rerun times pre- and postimplementation of the HemoCell at Gil Medical Center. Prothrombin time (PT), activated partial thromboplastin time (aPTT), D-dimer, and fibrinogen were evaluated.</p><p><strong>Results: </strong>The TAT standard deviations (SDs) and maximum TAT values decreased after HemoCell implementation, although the mean TATs for PT, aPTT, and D-dimer were increased. Numbers of rerun samples were increased (18.1/day vs 44.7/day). However, rerun times were reduced, and SDs were decreased during the post-HemoCell period compared with pre-HemoCell. Additionally, technologists needed smaller working space and less labor.</p><p><strong>Conclusion: </strong>The modular workcell could improve quality and efficiency by providing more consistent TATs and shorter rerun times in the hemostasis laboratory.</p>","PeriodicalId":17951,"journal":{"name":"Laboratory medicine","volume":"54 5","pages":"495-501"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Laboratory medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/labmed/lmac156","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Objective: Modular workcells could be a better solution than total laboratory automation (TLA) in hemostasis laboratories. Here, we evaluated the impact of implementing a modular workcell (HemoCell) with an intelligent data management facility (HemoHub).

Methods: We compared the turnaround times (TATs), numbers of rerun samples, and rerun times pre- and postimplementation of the HemoCell at Gil Medical Center. Prothrombin time (PT), activated partial thromboplastin time (aPTT), D-dimer, and fibrinogen were evaluated.

Results: The TAT standard deviations (SDs) and maximum TAT values decreased after HemoCell implementation, although the mean TATs for PT, aPTT, and D-dimer were increased. Numbers of rerun samples were increased (18.1/day vs 44.7/day). However, rerun times were reduced, and SDs were decreased during the post-HemoCell period compared with pre-HemoCell. Additionally, technologists needed smaller working space and less labor.

Conclusion: The modular workcell could improve quality and efficiency by providing more consistent TATs and shorter rerun times in the hemostasis laboratory.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
短期(6周)三级医院止血测试模块化工作单元的经验,包括智能数据管理器。
目的:模块化工作细胞比全实验室自动化(TLA)更好地解决止血实验室的工作问题。在这里,我们评估了采用模块化工作单元(HemoCell)和智能数据管理设施(hemhub)的影响。方法:我们比较了吉尔医疗中心血液细胞补充前后的周转时间(TATs)、回流样品数量和回流时间。测定凝血酶原时间(PT)、活化部分凝血活酶时间(aPTT)、d -二聚体和纤维蛋白原。结果:在HemoCell植入后,TAT标准差(SDs)和最大TAT值降低,但PT、aPTT和d -二聚体的平均TAT值升高。重新运行样本的数量增加(18.1/天vs 44.7/天)。然而,与hemocell前相比,重新运行时间减少,SDs在hemocell后期间减少。此外,技术人员需要更小的工作空间和更少的劳动力。结论:模块化工作细胞可提供更一致的TATs和更短的循环时间,提高了止血实验室的质量和效率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Robert L. Schmidt, MD, PhD, MBA (November 17, 1952-October 25, 2023) A 6-year-old boy with an atypical liver neoplasm harboring a novel RPS6KA3 variant. Evaluating direct amplification from viral transport medium for SARS-CoV-2 detection, strain typing, and angiotensin-converting enzyme genotyping and expression assays. Diagnostic value of pleural effusion Krebs von den Lungen-6 in malignant pleural effusion of patients with non-small cell lung cancer. Genetic analysis of TMPRSS6 catalytic domain variants in Mexican patients with iron treatment refractoriness.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1